| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue | (4,428) | 3,456 | 972 | 18,178 | | | Gross Profit | 4,428 | (3,456) | (972) | (18,178) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,274 | 6,673 | 6,784 | 8,182 | | Non Recurring | 5,315 |
-
|
-
|
-
| | Others | 125 | 88 | 69 | 60 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,286) | (10,217) | (7,825) | (26,420) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 224 | 296 | 331 | 659 | | Earnings Before Interest And Taxes | (7,062) | (9,921) | (7,494) | (25,761) | | Interest Expense |
-
|
-
|
-
| (11) | | Income Before Tax | (7,062) | (9,921) | (7,494) | (25,750) | | Income Tax Expense | 109 | 147 | 889 | (56) | | Minority Interest | (4,336) |
-
|
-
| (2,154) | | | | Net Income From Continuing Ops | (1,617) | (2,592) | (3,973) | (16,799) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,617) | (2,592) | (3,973) | (16,799) | | Preferred Stock And Other Adjustments | 2,400 | (1,597) | (803) |
-
| | | Net Income Applicable To Common Shares | $783 | ($4,189) | ($4,776) | ($16,799) |
|
0.26% Nasdaq 
0.03 (0.56%) 
Income Statement
